NCT06996808View on ClinicalTrials.gov

Intrauterine Balloon (Bakri©) Versus Uterine Tamponade With Chitosan Gauze (Celox PPH©) in the Management of Postpartum Hemorrhage Refractory to Medical Treatmen

NANot yet recruitingINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2028

Study Completion Date

January 31, 2029

Conditions

Postpartum Hemorrhage

Interventions

DEVICE

Bakri Baloon

Bakri Balloon Standard insertion and inflation as per hospital protocol following delivery.

DEVICE

Celox gauze

Celox gauze will be placed intrauterine according to manufacturer instructions, post-vaginal or cesarean delivery. Duration and removal will follow standardized clinical guidelines

All Listed Sponsors

lead

University of Roma La Sapienza

OTHER

NCT06996808 - Intrauterine Balloon (Bakri©) Versus Uterine Tamponade With Chitosan Gauze (Celox PPH©) in the Management of Postpartum Hemorrhage Refractory to Medical Treatmen | Biotech Hunter | Biotech Hunter